5 Year Antimicrobial Resistance Strategy 2013 to 2018
Country of origin: UK
Click for Full Details: www.gov.ukRecent guidance sets out actions to slow the development and spread of antimicrobial resistance with a focus on antibiotics.
Increasing resistance and a lack of new drugs means a greater risk of infections that cannot be treated. This will make routine medical care riskier and result in more deaths so antimicrobial resistance (AMR) affects us all.
The overall goal of this new cross-government UK strategy is to slow the development and spread of antimicrobial resistance by focusing activities around 3 strategic aims.
improve the knowledge and understanding of antimicrobial resistance
conserve and steward the effectiveness of existing treatments
stimulate the development of new antibiotics, diagnostics and novel therapies
The strategy confirms the UKs leading role in stimulating national and international action on this global issue and it is important that all sectors respond to the call for action if we are to successfully address this issue.
Click for Full Details: www.gov.uk
ASPET Pharmacology and Experimental Therapeutics September 2017
Genetic roadmap charts links between drugs and human disease September 2017
Tackling Drugs August 2017
Online Healthcare June 2017